Filing Flows › Utah Medical Products (UTMD) › Gross margin
Utah Medical Products (UTMD) gross margin by quarter
Utah Medical Products' gross margin was 55.8% in Q2 2026 (second quarter 2026), -4.8 pts from Q1 2026. Over the last 7 quarters it ranged from 55.8% (Q2 2026) to 60.6% (Q1 2026).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | 55.8% | -4.8 pts | -0.4 pts |
| Q1 2026 | 60.6% | +2.4 pts | +3.5 pts |
| Q4 2025 | 58.2% | +1.1 pts | +0.1 pts |
| Q3 2025 | 57.1% | +0.9 pts | — |
| Q2 2025 | 56.2% | -0.8 pts | — |
| Q1 2025 | 57.0% | -1.1 pts | — |
| Q4 2024 | 58.1% | — | — |
Q2 2026 at a glance
Utah Medical Products, Q2 2026: revenue $8.5M (-14% year over year), operating margin 31.1%, net earnings $2.7M, operating cash flow $1.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Utah Medical Products' gross margin?
Utah Medical Products' gross margin was 55.8% in Q2 2026 (second quarter 2026), -4.8 pts from Q1 2026.
How has Utah Medical Products' gross margin changed?
Over the last 7 quarters it ranged from 55.8% (Q2 2026) to 60.6% (Q1 2026).